Why is Aarti Pharma falling/rising?

As of 17-Sep, Aarti Pharmalabs Ltd is experiencing a price increase, currently at 918.80, reflecting a change of 7.25 (0.8%) upward. The stock has shown strong performance, outperforming its sector by 0.76% today. It is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating positive momentum. Over the past week, the stock has risen by 1.97%, and in the last month, it has surged by 21.35%. The company has also seen a significant increase in investor participation, with delivery volume rising by 50.78% against the 5-day average. Additionally, the stock's robust performance is highlighted by a 38.58% return over the past year, while profits have increased by 18.3%, supported by a low Debt to EBITDA ratio of 0.63 times and an attractive valuation.
In the broader market context, Aarti Pharmalabs has outperformed the benchmark, as the BSE500 has generated negative returns of -2.63% over the past year, contrasting sharply with the stock's impressive gains. The company's ability to maintain a strong return on capital employed (ROCE) of 16.1 and its favorable PEG ratio of 1.7 further bolster its position in the market. This performance, combined with its liquidity and strong fundamentals, suggests that Aarti Pharmalabs is well-positioned despite broader market challenges, contributing to its rising stock price.